The distinction between probiotics and postbiotics is central to the study. Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Postbiotics, by contrast, are the beneficial bioactive compounds produced by bacteria — including antimicrobial peptides, enzymes, and cell wall components — that can be harvested and applied without introducing living microbes into an animal or its environment. For aquaculture, an industry that has been searching for alternatives to antibiotics as it scales up worldwide, this distinction matters enormously. A live Vibrio strain, even a benign one, raises questions about safety, since the genus contains some of the most notorious pathogens of farmed fish and shellfish. A postbiotic preparation, however, could deliver the antimicrobial benefits while eliminating the risk that the microbe itself establishes an unwanted presence in rearing systems or in the fish gut.

To assess DCF12.2 thoroughly, the researchers first confirmed its taxonomic identity through genome-based analyses, which supported its classification as V. proteolyticus. They then examined the genome for biosynthetic gene clusters — groups of genes that work together to produce secondary metabolites, many of which have antimicrobial properties. The analysis revealed clusters associated with several distinct compound classes: arylpolyenes, which are pigmented molecules with antioxidant and antimicrobial activities; nonribosomal peptide metallophores of the amphibactin type, which are siderophores that bacteria use to scavenge iron from their surroundings; ectoine, a compatible solute that protects cells from osmotic stress; and hybrid RiPP-NRPS-like pathways, which combine elements of ribosomally synthesized and posttranslationally modified peptides with nonribosomal peptide synthetase machinery. Beyond these defined clusters, the genome also contained numerous predicted antimicrobial peptide candidates, suggesting a broad capacity for producing molecules that could inhibit competing bacteria.

The researchers also scrutinized the strain’s resistome — the collection of genes that confer resistance to antimicrobial agents. This is a critical consideration for any bacterium being considered for use in food animal production, since resistance genes can potentially transfer to pathogens and undermine antibiotic therapy. Encouragingly, the resistome of DCF12.2 was found to be composed mainly of chromosomal efflux and target-associated determinants. In other words, the resistance genes are built into the bacterium’s own chromosome rather than sitting on mobile genetic elements such as plasmids, which are notorious for shuttling resistance between species. This chromosomal localization reduces — though does not eliminate — the risk of horizontal gene transfer to other bacteria in a aquaculture setting.

Virulence was the other major safety concern. The team searched the genome for genes associated with disease-causing ability and found that virulence-related hits were largely restricted to functions linked to motility, chemotaxis, and secretion. These are common features of many marine bacteria and are not necessarily indicative of pathogenic potential on their own. However, the genome also contained sequences homologous to proteins previously described in Photobacterium damselae subsp. piscicida and Vibrio harveyi — two significant pathogens of farmed fish. The presence of these homologs, even if their function in DCF12.2 remains unclear, added to the authors’ caution about recommending the live strain for direct application. Additionally, the genome harbored three prophage regions — remnants of viruses that have integrated into the bacterial chromosome — and multiple genomic islands, which are stretches of DNA acquired through horizontal gene transfer. Together, these mobile genetic elements constitute what microbiologists call the mobilome, and their presence underscores the dynamic nature of the Vibrio genome.

Despite these genomic cautions, the phenotypic assays told a compelling story about the strain’s antimicrobial power. When the researchers tested DCF12.2 and its extracellular products (ECPs) — the mixture of molecules the bacterium releases into its environment — against a panel of relevant aquatic pathogens, they found inhibitory activity against three important species: Photobacterium damselae subsp. damselae, Vibrio harveyi, and Aeromonas hydrophila. These are not obscure laboratory organisms; they are among the most economically significant bacterial pathogens in aquaculture, responsible for diseases that cause substantial losses in fish farms around the world. The fact that a single marine isolate produces compounds active against all three is noteworthy and suggests that the antimicrobial arsenal of DCF12.2 is broad rather than narrow.

Particularly encouraging was the stability of the antimicrobial activity under conditions that might be encountered in real-world applications. The researchers found that the inhibitory activity of the extracellular products against P. damselae subsp. damselae was maintained after incubation at 37 degrees Celsius and after acidification to pH 5. These are meaningful benchmarks: 37 degrees Celsius approximates the internal body temperature of warm-blooded animals and is well above typical seawater temperatures, while pH 5 is moderately acidic — conditions that could occur in the digestive tract of fish or in fermented feed preparations. The fact that the antimicrobial compounds survive both heat and acid suggests they are robust molecules that could withstand the challenges of feed processing and passage through the gastrointestinal environment of the target animal.

Taken together, the genomic and phenotypic evidence led the authors to a clear recommendation: DCF12.2 is more suitable for use as a postbiotic than as a probiotic. The strain exhibits antimicrobial activity and other characteristics that would ordinarily qualify it as a probiotic candidate, but the presence of certain virulence factors tips the balance. By harnessing the extracellular products — the bacterium’s chemical weapons — rather than the living organism itself, aquaculture producers could potentially benefit from the antimicrobial compounds while sidestepping the biosafety concerns associated with introducing a Vibrio strain into fish rearing systems. This approach aligns with a growing trend in animal husbandry and human health alike, where postbiotics are increasingly recognized as a safer alternative to live microbial supplements.

The study also highlights the value of combining genomic analysis with phenotypic testing. Genome mining alone can identify biosynthetic gene clusters and predict antimicrobial potential, but it cannot confirm that those clusters are actually expressed and active under relevant conditions. Conversely, phenotypic assays can demonstrate antimicrobial activity without revealing the molecular basis or the genetic context that might raise safety concerns. By integrating both approaches, the researchers were able to build a comprehensive picture of DCF12.2 — its capacity for producing antimicrobial compounds, the stability of those compounds under stress, its resistome profile, and its virulence landscape. This integrated framework could serve as a model for evaluating other marine bacteria as sources of postbiotic compounds for aquaculture and beyond.

As the aquaculture industry continues to expand and faces mounting pressure to reduce antibiotic use, the search for natural antimicrobial alternatives has intensified. Marine bacteria, which live in competitive microbial communities where chemical warfare is a survival strategy, represent a largely untapped reservoir of bioactive compounds. The characterization of V. proteolyticus DCF12.2 adds a new candidate to this pipeline and demonstrates a rigorous, safety-conscious approach to evaluating environmental isolates. While further work will be needed to identify the specific antimicrobial molecules produced by the strain, to test their efficacy in live animal trials, and to develop practical delivery methods, the foundation laid by this study suggests that the gut of a wedge sole may hold lessons for the future of disease management in fish farming.

Subject of Research: Genomic and phenotypic characterization of the marine bacterium Vibrio proteolyticus and evaluation of its antimicrobial compounds for postbiotic applications in aquaculture

Article Title: Genomic and phenotypic characterization of Vibrio proteolyticus and its postbiotic potential

Article References: Genomic and phenotypic characterization of Vibrio proteolyticus and its postbiotic potential. (n.d.). https://doi.org/10.1007/s00253-026-14072-w

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14072-w

Keywords: Vibrio proteolyticus, postbiotic, aquaculture, antimicrobial peptides, biosynthetic gene clusters, resistome, virulence factors, extracellular products, marine microbiology, fish pathogens, Photobacterium damselae, probiotics